দেশ: আয়ার্লণ্ড
ভাষা: ইংরেজি
সূত্র: HPRA (Health Products Regulatory Authority)
TYLOSIN
Huvepharma NV
QJ01FA90
TYLOSIN
20 mg/g
Granules
POM
Porcine
Tylosin
Antibacterial
Authorised
2009-08-21
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE VETERINARY MEDICINAL PRODUCT Pharmasin 20 mg/g Oral Granules for pigs 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Tylosin (as tylosin phosphate) : 20 mg per g (equivalent to 20 000 IU) For the full list of excipients see section 6.1 3 PHARMACEUTICAL FORM Granules Light tan coloured, free flowing granules. 4 CLINICAL PARTICULARS 4.1 TARGET SPECIES Pigs. 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES Pigs: Treatment and prevention of clinical signs of porcine proliferative enteritis (porcine intestinal adenomatosis, proliferative hemorrhagic enteropathy, ileitis) associated with _Lawsonia intracellularis _when the disease has been diagnosed at the group level. 4.3 CONTRAINDICATIONS Do not use in animals with known hypersensitivity to the active substance and/or to any of the excipients of the product. Do not use in animals with known hypersensitivity to tylosin and other macrolides. Do not use where cross-resistance to other macrolides (MLS resistance) is suspected. Do not use in animals vaccinated with tylosin-sensitive vaccines either at the same time or within 1 week previously. Do not use in animals with hepatic disorders. Do not use in horses – danger of inflammation of the cecum. 4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES None. IRISH MEDICINES BOARD ________________________________________________________________________________________________________________________ _Date Printed 21/02/2014_ _CRN 7015172_ _page number: 1_ 4.5 SPECIAL PRECAUTIONS FOR USE Special precautions for use in animals This product is only for administration in small quantities of feed for immediate consumption, to individual animals. Animals with acute infections may have a reduced feed intake and should be treated with a suitable injectable product first. ‘Due সম্পূর্ণ নথি পড়ুন